Published in AIDS Weekly, April 21st, 2003
According to a recent study from the University of Arizona, HIV "results in progressive deterioration of the immune system in the majority of untreated hosts."
However, "peptide immunotherapy has been shown to be effective in the stimulation or immunoregulation of T-helper 1 (Th1) and T-helper 2 (Th2) response subsets," noted R. T. Sepulveda and colleagues.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.